As of Nov 25
| +0.02 / +0.32%|
The 5 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 15.00, with a high estimate of 40.00 and a low estimate of 12.00. The median estimate represents a +142.72% increase from the last price of 6.18.
The current consensus among 5 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.